Fig. 9From: Astaxanthin attenuates cognitive deficits in Alzheimer’s disease models by reducing oxidative stress via the SIRT1/PGC-1α signaling pathwayA Results of β-galactosidase staining of six groups of PC12 cells (bar = 50 µm). Comparison of β-galactosidase staining results. *P < 0.05, Control group vs. Aβ group and AST group; #P < 0.05, Aβ + AST + NAM group vs. Aβ + AST group and Aβ + NAM group; @P < 0.05, Aβ + AST group vs. Aβ groupBack to article page